← All articles

Remote COPD Exercise: Why Coaching May Matter Most

Remote COPD rehabilitation can improve fitness and quality of life, but a 2025 analysis finds devices work best with coaching, feedback, and goals.

Remote exercise programs may help people with COPD move more and function better, especially when they pair technology with structured coaching. The evidence supports modest-to-moderate short-term gains, not a replacement for high-quality in-person pulmonary rehabilitation or proof that an app can sustain progress indefinitely.

That distinction matters because COPD creates a large activity gap. In the systematic review by Han et al., people with COPD averaged 3,584 ± 3,360 steps per day, versus 9,372 ± 3,574 among healthy age-matched controls (p<0.0001). They also spent 24 ± 29 minutes per day in moderate-intensity activity, compared with 65 ± 70 minutes in controls (p<0.0001). Breathlessness can limit activity; lower activity then erodes conditioning and makes exertion harder. Pulmonary rehabilitation aims to interrupt that loop, but travel, access, illness, and program completion remain real barriers.

What the 2025 network meta-analysis found

A 2025 systematic review and network meta-analysis by Huan Tang et al. included 29 randomized controlled trials with 3,234 participants. It compared categories of remote exercise interventions and behavioral-support combinations, using face-to-face pulmonary rehabilitation as the reference comparator. Network meta-analysis can compare interventions that trials have not directly tested against each other, but those indirect comparisons require caution.

For exercise capacity, remote device-based exercise produced a standardized mean difference of 0.51 for six-minute walk distance, a moderate standardized effect. For health-related quality of life, application-based interventions produced an SMD of -0.67 on measures such as the St. George's Respiratory Questionnaire or COPD Assessment Test, where lower scores indicate improvement. The accessible abstract does not provide confidence intervals or full pairwise comparison matrices for these estimates, so it cannot establish the precision of every comparison or whether each effect met a conventional statistical-significance threshold.

The analysis also ranked intervention components with SUCRA probabilities. Programs combining motivation, feedback, and education ranked highly for six-minute walk distance. Combinations that included motivational interviewing, goal-setting, pedometer use, and education ranked highly for daily physical activity. A SUCRA ranking is a probability-based ordering, not a clinical protocol and not proof that the top-ranked package will outperform every alternative in a new patient.

Remote technology looks most useful as a delivery channel for exercise plus accountability, feedback, and practical support—not as a substitute for the human part of rehabilitation.

Why the behavioral layer has support

The ranking pattern fits evidence outside the network analysis. A 2025 systematic review and meta-analysis by Diciolla et al. found that structured physical-activity coaching in COPD improved physical-activity outcomes. These one-to-one interventions used behavior-change techniques such as motivation, feedback, and health education. The result supports coaching as an active part of the intervention rather than decorative packaging around a wearable.

Step counters also have a plausible, tested role. Han et al. reviewed pedometer-based physical-activity promotion programs and found measurable increases in daily steps across COPD trials. A pedometer does not improve lung function by moral persuasion. It can, however, make behavior visible, support a specific goal, and give patients and clinicians something concrete to discuss.

In a separate 2021 study, Armstrong et al. found that behavioral-modification interventions alongside standard pulmonary rehabilitation improved patients' experiences of physical activity, including amount and difficulty domains measured with the C-PPAC instrument. Together, these findings make the broad case for behavioral support stronger than any single app or device category.

The outcome still matters

Exercise capacity, daily steps, quality of life, and motivation are related, but they are not interchangeable. A better six-minute walk distance does not automatically prove sustained changes in free-living activity. More steps do not guarantee an improvement in quality of life. And a change in motivation is not the same as completing an exercise program for a year.

That is why the outcome-specific rankings in the network meta-analysis are useful but easy to overread. Device-based exercise had the reported moderate effect on six-minute walk distance, while application-based interventions had the reported quality-of-life effect. The analysis did not show that one remote format is universally best. It suggested that the combination of format and behavioral support may need to match the goal.

Another 2025 review, Tang X et al., examined remote respiratory rehabilitation in stable COPD, including outcomes related to acute exacerbations. It adds to the remote-rehabilitation literature, but it does not erase the uncertainty around which program design works best for a particular severity level or how long benefits persist.

Where the optimistic reading breaks down

The behavioral story has limits. In a pragmatic randomized controlled trial, Rausch Osthoff et al. found that counseling during in-person pulmonary rehabilitation had only limited effects on self-determined motivation for physical activity. That result does not refute goal-setting or feedback, but it challenges the idea that motivational-interviewing-style counseling reliably changes intrinsic motivation in COPD.

Psychological comorbidity may also change the result. In a 2023 study, Armstrong et al. reported mixed results when cognitive behavioral therapy and physical-activity behavioral-modification strategies were added during pulmonary rehabilitation for COPD patients with comorbid anxiety or depression. People with anxiety or depression may need more than a standard stack of education, goals, and messages. The network rankings cannot guarantee equal benefit in that subgroup.

Durability is the other weak point. A 12-month randomized trial by Galdiz et al. tested telerehabilitation as a maintenance strategy after in-person pulmonary rehabilitation and documented uncertainty about whether telehealth approaches sustain gains from intensive rehabilitation. Program-end improvements are useful, but they should not be treated as permanent.

How much confidence should you place in the rankings?

Tang et al. rated the GRADE quality of evidence low to very low across remote intervention types. Exercise and behavioral trials often cannot blind participants or staff, and many included trials had unclear allocation-concealment or blinding assessments. Protocols also varied: "motivational interviewing" can mean materially different sessions, training, and fidelity across trials.

The network adds further uncertainty. Less-studied combinations depend heavily on indirect comparisons, and the accessible abstract does not allow readers to verify agreement between direct and indirect estimates. The available information also does not establish whether the six-minute-walk benefit concentrated in people with severe limitation or applied similarly across milder COPD. No large trial with more than 200 participants appears in this evidence base, and the abstract does not quantify adherence or dropout across the included trials. Small studies and trial-level adherence can make a remote program look better than it will in routine care.

A practical verdict

For someone planning remote COPD exercise support, the best-supported ingredients are ordinary ones: a tolerable exercise plan, explicit goals, step-count or activity feedback, education, and ongoing coaching. Those elements have support across the network analysis, physical-activity coaching evidence, and pedometer-based programs. They do not make remote care superior to face-to-face pulmonary rehabilitation for people who can access it.

Use the 2025 rankings as a map for testing and tailoring programs, not a prescription. The next useful trials need larger samples, standardized delivery of behavioral support, analyses by COPD severity, and follow-up of at least 12 months. Until then, remote rehabilitation offers a reasonable route to short-term improvement for many patients—provided the program includes more than a login and a cheerful notification.

Comments

No comments yet. Be the first!